Industry News
Deepson Bio Receives Presidential Award at 2025 Korea Invention Patent Exhibition
Award highlights promise of ultrasound-based innovation in addressing unmet needs in dementia treatment SEOUL, South Korea, Jan. 12, 2026 /PRNewswire/ -- Deepson Bio Co., Ltd., a medical technology company focused on ultrasound-based approaches to dementia treatment, was honored with the Preside...
2026-01-12 22:00
705
Insilico Medicine Completes First Patient First Dose in BETHESDA: A Phase II Trial for Garutadustat (ISM5411), the Gut-restricted AI-driven PHD Inhibitor for the Treatment of Inflammatory Bowel Disease
CAMBRIDGE, Mass., Jan. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"),
a clinical-stage, generative AI-driven drug discovery company, today announced
the completion of first patient first dose in BETHESDA: a Phase IIa clinical
trial of ISM5411 (NCT07265570
2026-01-12 21:30
813
NTA Launches Energy-Efficient Valve Solutions for Faster and More Sustainable Automation
NINGBO, China, Jan. 12, 2026 /PRNewswire/ -- Pneumatic components are widely
used in factories for their simplicity and reliability. However, rising demands
for speed, cost control, and sustainability are forcing manufacturers to
rethink how much energy these systems consume.
2026-01-12 21:16
879
WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing
SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform designed to transform bioprocess development and manufactur...
2026-01-12 21:09
1902
CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
SHANGHAI, PHILADELPHIA and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, and Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveragin...
2026-01-12 21:05
1406
Leadgene Biosolutions Expands Its Product Portfolio Following Strategic Integration, Advancing Early-Stage Mixing and Long-Term Metabolic Insight
TAIPEI, Jan. 12, 2026 /PRNewswire/ -- Leadgene Biosolutions today announces the expansion of its product portfolio following its strategic integration into Leadgene Biomedical. The expanded portfolio supports both early-stage cell line development and long-term metabolic research, enabling resear...
2026-01-12 21:00
1184
PETKIT Recognized at CES 2026 with Multiple Best of CES Honors for Smart Pet Care
YUMSHARE DAILY FEAST named a finalist in CNET's Best of CES Awards and winner
of the Future Innovation Awards – Best of CES 2026; PETKIT also earns the
Microsoft AI Innovation Award for applying AI to real-world pet health
challenges
LOS ANGELES, Jan. 12, 2026 /PRNewswire/ -- PETKIT
2026-01-12 21:00
1315
ECARX Holdings Inc. Announces US$45.6 million Strategic Investment from Geely Holding Group
LONDON, Jan. 12, 2026 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility tech provider, today announced that it has entered into a subscription agreement with Geely Investment Holding Ltd. ("Geely Holding") onJanuary 8th, 2026. Under the terms of the a...
2026-01-12 20:04
2189
Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion
HSK39004, a novel dual‑target therapy, aims to compete in the global COPD market, highlighting innovation and international capabilities BEIJING, Jan. 12, 2026 /PRNewswire/ -- On January 9, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an ex...
2026-01-12 20:00
872
Equity Acquisition of Nanyue Diankong (Hengyang) Industrial Technology
SINGAPORE, Jan. 12, 2026 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD)("China Yuchai" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary inChina, Guangxi Yuchai Machinery Company Limited ("Yuchai"), wishes to announce tha...
2026-01-12 19:00
3912
TAL Education Group to Announce Third Quarter of Fiscal Year 2026 Financial Results on January 29, 2026
BEIJING, Jan. 12, 2026 /PRNewswire/ -- TAL Education Group ("TAL" or the "Company") (NYSE: TAL), a smart learning solutions provider inChina, today announced that it will release its unaudited financial results for the third quarter of fiscal year 2026 endedNovember 30, 2025, before the market o...
2026-01-12 17:30
166
WuXi AppTec Issues Positive Profit Alert for the Full Year of 2025
SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today issued a Positive Profit Alert for the full year of 2025, disclosing forecasts of key operational data...
2026-01-12 17:30
900
ECOVACS Gains Further International Recognition as a Service Robotics Leader, Winning Three GTB Awards at CES 2026
LAS VEGAS, Jan. 12, 2026 /PRNewswire/ -- The Global Top Brands Award Ceremony and International Consumer Electronics Industry Leaders' Summit were held on January 7, 2026, in Las Vegas, USA. This event marked the 20th anniversary of the Global Top Brands (GTB) selection. And ECOVACS ROBOTICS once ...
2026-01-12 17:19
1152
XPENG Charts New Course in 2026: Flagship Launch, Sales Momentum, and AI Breakthrough Propel Global Technology Ambitions
GUANGZHOU, China, Jan. 12, 2026 /PRNewswire/ -- XPENG is ushering in 2026 with transformative momentum, reinforcing its strategic evolution into an AI-driven global technology leader. The company unveiled its next-generation flagship model, celebrated a critical production milestone, and introduc...
2026-01-12 16:14
1389
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
TAIPEI, Jan. 12, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Samil Pharmaceuticals, Co., Ltd ("Samil", 000520.KS), for exclusive rights to the commercialization of clobetasol...
2026-01-12 16:00
1034
BOYA Notra Redefines Note-Taking with All Scenario Recording Modes
NEW YORK, Jan. 12, 2026 /PRNewswire/ -- BOYA, a global leader in professional
audio equipment, today announcedBOYA Notra
2026-01-12 15:31
455
RoboChallenge's Top-Ranked Embodied AI Model Goes Open Source, Challenging Clean Data Collection Paradigm
BEIJING, Jan. 12, 2026 /PRNewswire/ -- Spirit AI, an embodied AI startup, today announced that its latest VLA model, Spirit v1.5, has ranked first overall on the RoboChallenge benchmark.To drive industry transparency and collaborative growth, Spirit AI is open-sourcing its foundation model alongs...
2026-01-12 14:41
309
FIRSTHABIT Successfully Concludes CES 2026 CHALK AI Math Challenge Once Again and Announces Winners
SEOUL, South Korea, Jan. 12, 2026 /PRNewswire/ -- Edtech company FIRSTHABIT successfully concluded the CHALK AI Math Challenge held during CES 2026, the world's largest consumer electronics and IT exhibition, inLas Vegas, the United States, and announced the final winners of the competition. Thro...
2026-01-12 14:34
736
Tuya Smart Launches Aura, an AI Companion Robot Designed for Pets
LAS VEGAS, Jan. 12, 2026 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a
global AI cloud platform service provider, officially unveiled Aura, its first
AI-powered pet companion robot, at CES 2026, the world's largest consumer
electronics show.
2026-01-12 13:25
1018
Clover Initiates Phase 2 Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
-- Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's
Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates --
SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.
2026-01-12 12:33
114
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 319 media titles]
2026-01-23 11:03
Agoda Launches Agoda Impact Lab at ASEAN Tourism Forum
[Picked up by 318 media titles]
2026-01-29 15:06
Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 309 media titles]
2026-01-27 13:00
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 307 media titles]
2026-01-23 09:00Nokia Strengthens Edge AI Capabilities Through Strategic Collaboration with Blaize on Hybrid Inference Solutions Across Asia Pacific Regions
[Picked up by 294 media titles]
2026-01-27 18:00
Most Read
Robo.ai Partners with The Ghazi Group to Power AI Compute Infrastructure Growth in MENA and Southeast Asia
2026-01-23 19:02
8570
